A double-blind, crossover study of Doxazosin and Enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea patients

Sleep Medicine

Volumn 11, Issue 3, 2010, Pages 325-328

  Zou, Ding ^a   Grote, Ludger ^a   Eder, Derek N ^a   Radlinski, Jakub ^b   Hedner, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Institute for Tuberculosis and Lung Diseases   (Poland)

Author keywords

Antihypertensive treatment; Autonomic nervous system; Blood pressure; Obstructive sleep apnea; Peripheral arterial tone; Pulse wave attenuation

Indexed keywords

ALFADIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; ENALAPRIL MALEATE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ADULT; AGED; ARTERY TONE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD VESSEL TONE; BODY MASS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; HUMAN; HYPERTENSION; MALE; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DOXAZOSIN; ENALAPRIL; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP; SLEEP APNEA, OBSTRUCTIVE; VASOCONSTRICTION;

EID: 77149142593     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2009.10.004     Document Type: Article

References (18)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 19 (2003) 2560-2572
2. Worsnop C.J., Naughton M.T., Barter C.E., Morgan T.O., Anderson A.I., and Pierce R.J. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 157 1 (1998) 111-115
3. Hedner J., Ejnell H., Sellgren J., Hedner T., and Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 6 4 (1988) S529-S531
4. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J.R., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 9302 (2002) 204-210
5. Logan A.G., Tkacova R., Perlikowski S.M., Leung R.S., Tisler A., Floras J.S., et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 21 2 (2003) 241-247
6. Kraiczi H., Hedner J., Peker Y., and Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 161 5 (2000) 1423-1428
7. Salo T.M., Kantola I., Voipio-Pulkki L.M., Pelttari L., and Viikari J.S. The effect of four different antihypertensive medications on cardiovascular regulation in hypertensive sleep apneic patients - assessment by spectral analysis of heart rate and blood pressure variability. Eur J Clin Pharmacol 55 3 (1999) 191-198
8. Schnall R.P., Shlitner A., Sheffy J., Kedar R., and Lavie P. Periodic, profound peripheral vasoconstriction - a new marker of obstructive sleep apnea. Sleep 22 7 (1999) 939-946
9. Bar A., Pillar G., Dvir I., Sheffy J., Schnall R.P., and Lavie P. Evaluation of a portable device based on peripheral arterial tone for unattended home sleep studies. Chest 123 3 (2003) 695-703
10. Zou D., Grote L., Peker Y., Lindblad U., and Hedner J. Validation a portable monitoring device for sleep apnea diagnosis in a population based cohort using synchronized home polysomnography. Sleep 29 3 (2006) 367-374
11. Zou D., Grote L., Eder D.N., Peker Y., and Hedner J. Obstructive apneic events induce alpha-receptor mediated digital vasoconstriction. Sleep 27 3 (2004) 485-489
12. Taylor S.H., Lee P.S., and Sharma S.K. A comparison of doxazosin and enalapril in the treatment of mild and moderate essential hypertension. Am Heart J 116 6 Pt 2 (1988) 1820-1825
13. Ebbs D. A comparison of selected antihypertensives and the use of conventional vs. ambulatory blood pressure in the detection and treatment of hypertension. Cardiology 96 1 (2001) 3-9
14. Ben-Dov I.Z., Ben-Arie L., Mekler J., and Bursztyn M. How should patients treated with alpha-blockers be followed? Insights from an ambulatory blood pressure monitoring database. J Hypertens 24 5 (2006) 861-865
15. Kario K., Schwartz J.E., and Pickering T.G. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the HALT study. Hypertension 35 3 (2000) 787-794
16. Grassi G., Seravalle G., Stella M.L., Turri C., Zanchetti A., and Mancia G. Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs. Am J Hypertens 13 1 (2000) 29-34
17. Nitzan M., Glikberg F., Fidel J., Gross C., Bar-On H., and Mahler Y. The relationship between systolic blood pressure and microvascular resistance in non-diabetic and diabetic subjects. J Basic Clin Physiol Pharmacol 3 3 (1992) 193-205
18. Zou D., Grote L., Radlinski J., Eder D.N., Lindblad U., and Hedner J. Nocturnal pulse wave attenuation is associated with office blood pressure in a population based cohort. Sleep Med 10 8 (2009) 836-843